Palisade Bio
PALI
7 hedge funds and large institutions have $57.1M invested in Palisade Bio in 2014 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 0 closing their positions.
31% more call options, than puts
Call options by funds: $893K | Put options by funds: $681K
17% more funds holding
Funds holding: 6 → 7 (+1)
0% more ownership
Funds ownership: 0% → 0% (+0%)
17% less capital invested
Capital invested by funds: $68.5M → $57.1M (-$11.5M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Northern Trust
Chicago,
Illinois
|
+$4.03M |
| 2 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$4.03M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$1.18M |
| 2 |
SG Americas Securities
New York
|
-$193K |
| 3 |
CS
Cannell & Spears
New York
|
-$105K |
| 4 |
SCM
Stevens Capital Management
Radnor,
Pennsylvania
|
-$75K |
| 5 |
Tudor Investment Corp
Stamford,
Connecticut
|
-$51K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CS
76
Cannell & Spears
New York
| – | -$105K | – | – |
|
|
FCCM
77
First City Capital Management
Savannah,
Georgia
| – | -$42.2K | – | – |
|
|
GIA
78
GHP Investment Advisors
Denver,
Colorado
| – | -$42K | – | – |
|
|
79
Millennium Management
New York
| – | -$1.18M | – | – |
|
|
RHBC
80
R.H. Bluestein & Co
Birmingham,
Michigan
| – | -$46K | – | – |
|
|
81
SG Americas Securities
New York
| – | -$193K | – | – |
|
|
SCM
82
Stevens Capital Management
Radnor,
Pennsylvania
| – | -$75K | – | – |
|
|
TAM
83
Tocqueville Asset Management
New York
| – | -$4K | – | – |
|
|
84
Tudor Investment Corp
Stamford,
Connecticut
| – | -$51K | – | – |
|
|
VFA
85
Virtus Fund Advisers
Hartford,
Connecticut
| – | -$25K | – | – |
|
PALI Hedge Fund Activity: Q3 2014 in Review
7 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Palisade Bio (PALI) for Q3 2014, worth a combined $57.1M — down 17% from $68.5M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new PALI positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Northern Trust, opening a new position worth an estimated $4.03M. The largest seller was Millennium Management, cutting an estimated $1.18M.
- 7 institutional investors held Palisade Bio (PALI) as of Q3 2014, up from 6 in Q2 2014.
- Funds reported $57.1M of Palisade Bio stock for Q3 2014, down 17% quarter-over-quarter.
- 1 fund opened new Palisade Bio positions in Q3 2014 and 0 closed out, a net change of +1 holder.
- The largest Palisade Bio buyer in Q3 2014 was Northern Trust, an estimated $4.03M added.
- The largest Palisade Bio seller in Q3 2014 was Millennium Management, an estimated $1.18M sold.
Based on aggregated 13F filings for Q3 2014.